Dyne Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$15.72(as of Oct 26, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Dyne Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$15.72
Ticker SymbolDYN
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees289
CountyUSA
Market Cap$2,917.0M
EBIDTA-534.8M
10-Day Moving Average15.46
P/E Ratio-5.01
20-Day Moving Average15.68
Forward P/E Ratio0.00
50-Day Moving Average19.28
Earnings per Share-3.30
200-Day Moving Average19.32
Profit MarginUnknown
RSI42.39
Shares Outstanding186.7M
ATR0.89
52-Week High27.31
Volume1,741,931
52-Week Low14.00
Most Recent Support Level15.32
Book Value702.2M
Most Recent Resistance Level16.73
P/B Ratio3.70
Upper Keltner17.68
P/S RatioUnknown
Lower Keltner13.69
Debt-to-Equity Ratio0.03
Next Earnings Date11/04/2026
Cash Surplus598.1M
Next Ex-Dividend DateUnknown

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Dyne Therapeutics Inc In Our Stock Scanner

As of Oct 26, 2026
example chart graphic
Scan Name: Death CrossScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.